Indoco Remedies shares gain on final USFDA approval for Pregabalin capsules

The share touched a 52-week high of Rs 416.95 and a 52-week low of Rs 308.80 on January 1, 2024, and October 26, 2023, respectively.

Related Keywords

India ,Aditi Panandikar ,Drug Administration ,Abbreviated New Drug Application ,Indoco Remedies ,Reference Listed Drug ,Verna Industrial Area ,